医学
促炎细胞因子
神经科学
癌症
中枢神经系统
骨癌
小胶质细胞
癌细胞
炎症
生物信息学
生物
免疫学
内科学
作者
Ya‐Qun Zhou,Zheng Liu,Hui-Quan Liu,Dai-Qiang Liu,Shuping Chen,Dawei Ye,Yuan Tian
标识
DOI:10.1080/14728222.2016.1214716
摘要
Bone cancer pain (BCP) remains to be a clinical challenge with limited pharmaceutical interventions. Therefore, novel therapeutic targets for the management of BCP are in desperate need. Recently, a growing body of evidence has suggested that glial cells may play a pivotal role in the pathogenesis of BCP. Areas covered: This review summarizes the recent progress in the understanding of glia in BCP and reveals the potential therapeutic targets in glia for BCP treatment. Expert opinion: Pharmacological interventions inhibiting the activation of glial cells, suppressing glia-derived proinflammatory cytokines, cell surface receptors, and the intracellular signaling pathways may be beneficial for the pain management of advanced cancer patients. However, these pharmacological interventions should not disrupt the normal function of glia cells since they play a vital supportive and protective role in the central nervous system.
科研通智能强力驱动
Strongly Powered by AbleSci AI